GREGORY P HANSON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY P HANSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY P HANSON. GREGORY P HANSON is a Vice President, CAO in AVANIR PHARMACEUTICALS, INC. ($AVNR) and a Vice President, Finance in AVANIR PHARMACEUTICALS, INC. ($AVNR) and a VP, CAO & Secretary in AVANIR PHARMACEUTICALS, INC. ($AVNR) and a Chief Financial Officer in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and a CHIEF FINANCIAL OFFICER, SECR in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
Address: 11388 SORRENTO VALLEY ROAD, SUTIE 200 SAN DIEGO 92121 CA
Companies in which GREGORY P HANSON is an Insider
AVANIR PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY P HANSON: VP, CAO & Secretary, Vice President, CAO, Vice President, Finance
Holdings: 22,563 shares
Latest Transaction: Dec 14 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MABVAX THERAPEUTICS HOLDINGS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY P HANSON: CHIEF FINANCIAL OFFICER, SECR, Chief Financial Officer
Holdings: 320,013 shares
Current Value: $950,439
Latest Transaction: Feb 23 2018
$MBVX Market Capitalization: $18.01M
$MBVX Previous Close: $2.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GREGORY P HANSON
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
| Jan 18 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.92 | 41,873 | 38,523 | 320,013 | 361.9 K to 320 K (-11.57 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 449,159 | 0 | 0 | |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.96 | 11,232 | 10,783 | 361,886 | 373.1 K to 361.9 K (-3.01 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.98 | 38,697 | 37,923 | 373,118 | 411.8 K to 373.1 K (-9.40 %) |
| Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.96 | 66,550 | 63,888 | 411,815 | 478.4 K to 411.8 K (-13.91 %) |